Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
about
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.Practical guide to the management of acute and chronic pain in the presence of drug tolerance for the healthcare practitioner.Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant resultsPharmacological and toxicological profile of opioid-treated, chronic low back pain patients entering a mindfulness intervention randomized controlled trial.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.Substance use disorders in a primary care sample receiving daily opioid therapy.Survey of select practice behaviors by primary care physicians on the use of opioids for chronic painBuprenorphine Prescribing: To Expand or Not to ExpandManagement of chronic pain with chronic opioid therapy in patients with substance use disordersPerceptions of Community-Dwelling Patients and Their Physicians on OxyContin® Discontinuation and the Impact on Chronic Pain Management.Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction.Intake assessment of problematic use of medications in a chronic noncancer pain clinic.2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 2: populations particulières.
P2860
Q33753044-D5CED99A-9C8B-45DD-89A5-0B09E437C280Q34228635-831E7464-4711-4B88-9C23-CFEFDFB5430BQ34566925-78F06441-709E-4215-8965-B9AA921523B8Q35064172-1B621BC7-D2D2-4C52-8A82-D85BE99C4B41Q35548503-292602F7-2CE2-4898-BD8F-85C7CB065DF9Q35740890-C726DAF5-1A24-4FB2-BEBC-2FA8EFE809F7Q35941859-2B873D6D-F330-4768-81A9-0B39A6114337Q35962711-C2F865BE-EDB7-4C7E-935B-82624AF5FA9BQ35962717-5AC3165F-C20F-4E05-8A71-394A2520785FQ36855631-0B24B564-988B-4D57-912F-24329BC54AAEQ37523766-00974E8B-472A-4308-8604-3086FEFF76EFQ37637803-75A50896-A3D9-4F74-BC87-1D517BB86402Q38820699-4D0B6969-D060-4131-8235-43125F6CB9B7Q41773214-4B6A0AF7-54BD-4259-8D64-D1C734E1FD99Q41919082-1D098A7F-A26A-4B8F-A7E6-58C9C338A3A2Q45871173-75FDCD89-2E19-45DE-87D9-7CD2ED767D2A
P2860
Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Does random urine drug testing ...... in patients receiving opioids?
@en
Does random urine drug testing ...... in patients receiving opioids?
@nl
type
label
Does random urine drug testing ...... in patients receiving opioids?
@en
Does random urine drug testing ...... in patients receiving opioids?
@nl
prefLabel
Does random urine drug testing ...... in patients receiving opioids?
@en
Does random urine drug testing ...... in patients receiving opioids?
@nl
P2093
P1476
Does random urine drug testing ...... in patients receiving opioids?
@en
P2093
Carla D McManus
Doris E Brandon
Kim A Cash
Kim S Damron
Laxmaiah Manchikanti
Rajeev Manchukonda
Vidyasagar Pampati
P304
P577
2006-04-01T00:00:00Z